EDWARD M BARON

Allopathic & Osteopathic Physicians|Ophthalmology VALLEY STREAM, NY NPI 1699770586

General Payments — all program years on this page

$2,250.06

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 83
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $472.52 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $472.5219

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $325.2912
Alexion Pharmaceuticals, Inc. $68.983
Tarsus Pharmaceuticals, Inc. $24.001
Alcon Laboratories Inc $21.551
Thea Pharma Inc. $17.981
Harrow Eye, LLC $14.721

By program year

Program yearAmountRecords
2018 $14.321
2019 $161.668
2020 $225.8710
2021 $182.019
2022 $435.7713
2023 $757.9123
2024 $472.5219

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1074539327 Thea Pharma Inc. $17.98 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093920663 Alexion Pharmaceuticals, Inc. $21.10 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1094008510 Alexion Pharmaceuticals, Inc. $21.10 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1094025677 Alexion Pharmaceuticals, Inc. $26.78 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110683991 Alcon Vision LLC $21.55 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111524972 Amgen Inc. $16.44 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111524974 Amgen Inc. $20.44 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111524976 Amgen Inc. $6.49 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111524978 Amgen Inc. $6.10 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111524980 Amgen Inc. $23.87 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111524982 Amgen Inc. $121.84 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111524984 Amgen Inc. $16.83 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111524986 Amgen Inc. $25.17 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111524988 Amgen Inc. $29.32 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111524990 Amgen Inc. $3.66 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111524992 Amgen Inc. $24.11 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111524994 Amgen Inc. $31.02 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139081333 Tarsus Pharmaceuticals, Inc. $24.00 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145597863 Harrow Eye, LLC $14.72 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.